Evidence map›Paper›PMID 39364591›Full record

ArticleCirculation. Cardiovascular quality and outcomes2024

Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries.

Emily P Zeitler, Boyang Bian, Robert I Griffiths, Dominic J Allocco, Thomas Christen, Kristine Roy, David J Cohen, Matthew R Reynolds

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emily P ZeitlerDartmouth Health and The Dartmouth Institute, Lebanon, NH (E.P.Z.).ORCID 0000-0002-4848-4775
Boyang BianBoston Scientific, Marlborough, MA (B.B., D.J.A., T.C., K.R.).
Robert I Griffiths
Dominic J AlloccoBoston Scientific, Marlborough, MA (B.B., D.J.A., T.C., K.R.).ORCID 0000-0002-0577-1555
Thomas ChristenBoston Scientific, Marlborough, MA (B.B., D.J.A., T.C., K.R.).
Kristine RoyBoston Scientific, Marlborough, MA (B.B., D.J.A., T.C., K.R.).
David J CohenCardiovascular Research Foundation, New York, NY (D.J.C.).ORCID 0000-0001-9163-724X
Matthew R ReynoldsBaim Institute for Clinical Research, Brookline, MA (M.R.R.).ORCID 0000-0001-8675-8186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term outcomes following left atrial appendage occlusion outside clinical trials and small registries are largely unknown. Collecting these data was a condition of US market authorization of the WATCHMAN device. The aim of this analysis was to evaluate the rates of stroke, bleeding, and death among Medicare beneficiaries following left atrial appendage occlusion implantation during initial commercial availability of the WATCHMAN left atrial appendage occlusion device overall and in important subgroups.

methodsAll Medicare fee-for-service beneficiaries ≥65 years of age who underwent left atrial appendage occlusion from April 1, 2016, to August 31, 2020, were included based on the

resultsWATCHMAN recipients (n=48 763) were a median of 77 (interquartile range, 72-82) years of age, 42% female, and mostly White (93%). The median CHA

conclusionsCompared with patients enrolled in the pivotal clinical trials, Medicare beneficiaries undergoing WATCHMAN implantation were older, more female, and had more comorbid conditions. Substantial long-term mortality and major bleeding following WATCHMAN reflect the high-risk nature of the patient population, while the ischemic stroke rate was relatively low (<1.5% per year).

Indexed as

Atrial AppendageAtrial FibrillationHemorrhageInsurance BenefitsIschemic StrokeMedicareAgedAged, 80 and overCardiac CatheterizationFee-for-Service PlansFemaleHumansIncidenceMaleRetrospective StudiesRisk Assessmentatrial fibrillationhemorrhagemortalitystroke

Identifiers

PMID39364591
PMCPMC11485207

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.